Caris Life Sciences Inc. (CAI) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Caris Life Sciences Inc. (CAI) advanced +1.95% to $36.14 as options desks priced 56% call premium vs. 44% put protection around the $35 max-pain magnet. Solid 41% profit margin (4% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.
Viatris (VTRS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Caris Life Sciences,?Inc. (CAI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BTIG analyst Mark Massaro maintains Caris Life Sciences (NASDAQ:CAI) with a Buy and raises the price target from $33 to $38.
BOSTON, October 22, 2026--Foundation Medicine appoints Chadi Nabhan, M.D., MBA, as chief medical officer.
Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced the launch of the second commercial in a series promoting Caris Detect™, Caris' multi-cancer early detection (MCED) test, featuring three-tim
Canaccord Genuity analyst Kyle Mikson maintains Caris Life Sciences (NASDAQ:CAI) with a Hold and raises the price target from $22 to $30.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +97.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CAI today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CAI. Explore sector supply chains on /butterfly.
Why CAI Stock advanced +1.95% Today — RQD Quant Desk Flash. Solid 41% profit margin (4% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.